# Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Reperfusion Therapy

> **NCT06538844** · PHASE2 · COMPLETED · sponsor: **Capital Medical University** · enrollment: 134 (actual)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** Intravenous infusion of human albumin
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT06538844
- **Lead sponsor:** Capital Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-08-10
- **Primary completion:** 2024-12-20
- **Final completion:** 2025-03-15
- **Target enrollment:** 134 (ACTUAL)
- **Last updated:** 2025-04-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06538844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06538844, "Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Reperfusion Therapy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06538844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*